Ottawa Nutritional Guidelines for Nausea and Vomiting

Nausea Gravidarum Clinical Trial

Official title:

Effect of Implementing Ottawa Nutritional Guidelines on the Course of Nausea and Vomiting During Pregnancy (A Randomized Control Trial)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05370170
• Other study ID #: IORG0003381
• Status: Completed
• Phase: N/A
• Start date: January 1, 2021
• Est. completion date: September 30, 2021

Study information

• Verified date: May 2022
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Effect of Implementing Ottawa Nutritional Guidelines on the Course of Nausea and Vomiting During Pregnancy (A Randomized Control Trial)

Description:

Studying the Effect of Implementing Ottawa Nutritional Guidelines on the Course of Nausea and Vomiting During Pregnancy (A Randomized Control Trial) using no pharmacological agents and life style modification in addition to acupressure to treat nausea and vomiting of pregnancy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: September 30, 2021
• Est. primary completion date: September 30, 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 22 Years to 35 Years

Eligibility

Inclusion Criteria:

1. primigravida

2. gestational age of 7-13 weeks

3. singleton pregnancy

4. having a score of 7-12 on the (PUQE 24)

5. can read and write

6. having phone number

7. not receiving medications for reducing NVP, except for vitamin B6

8. wanted pregnancy.

Exclusion Criteria:

1. subject's unwillingness to continue the study

2. occurrence of obstetric complications during the study

3. hyper-emesis gravidarum

4. having physical or mental disorders

5. having oral/speech impairments

6. having assisted reproductive techniques for the present pregnancy

7. having two consecutive miscarriages before the current pregnancy

8. old primigravida

9. narcotic use or alcohol drinking

10. and subjects who will show signs and symptoms of hyperemesis gravidarum during the study will be dropped out and referred to medical care.

Related Conditions & MeSH terms

• Nausea
• Nausea Gravidarum
• Vomiting

Intervention

Behavioral:
• Acupressure and nutritional advices
Teaching using booklets and application of acupressure

Locations

Country	Name	City	State
Egypt	Faculty of Nursing	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	control nausea and vomiting	control the frequency and severity of nausea and vomiting and measure it by using Pregnancy Unique Quantification of Emesis	3 weeks
Secondary	maintain normal body weight and prevent hospitalization	Monitor mother weight by calipered weight scale to monitor weight loss related to nausea and vomiting	3 weeks